Analysis Of Income And Expense [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
2023-01-01 to 2023-12-31 |
|---|---|---|
| Analysis of income and expense [abstract] | ||
| Revenue [abstract] | ||
| Revenue |
274,249,000
EUR
|
266,234,000
EUR
|
| Expenses by nature [abstract] | ||
| Classes of employee benefits expense [abstract] | ||
| Employee benefits expense |
45,699,000
EUR
|
54,345,000
EUR
|
| Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract] | ||
| Depreciation and amortisation expense [abstract] | ||
| Depreciation and amortisation expense |
31,732,000
EUR
|
21,841,000
EUR
|
| Other expenses, by nature |
20,946,000
EUR
|
26,915,000
EUR
|
| Disclosure of attribution of expenses by nature to their function [text block] | — | — |
| Disclosure of attribution of expenses by nature to their function [abstract] | ||
| Disclosure of attribution of expenses by nature to their function [line items] | ||
| Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract] | ||
| Share of profit (loss) of associates accounted for using equity method |
-
EUR
|
561,000
EUR
|
| Comprehensive income, continuing and discontinued operations [abstract] | ||
| Comprehensive income |
19,704,000
EUR
|
28,931,000
EUR
|